Related references
Note: Only part of the references are listed.Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE
Michelle A. Petri et al.
LUPUS SCIENCE & MEDICINE (2019)
TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus
Helena Idborg et al.
LUPUS SCIENCE & MEDICINE (2018)
Comment on: Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus: reply
Christian Lood et al.
RHEUMATOLOGY (2017)
Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
Johanna T. Gustafsson et al.
PLOS ONE (2017)
Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development
Saravanan Subramaniam et al.
BLOOD (2017)
Complement and thrombosis in the antiphospholipid syndrome
Kenji Oku et al.
AUTOIMMUNITY REVIEWS (2016)
Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations
Fariborz Mobarrez et al.
SCIENTIFIC REPORTS (2016)
Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus
Christian Lood et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Platelets and the complement cascade in atherosclerosis
Johannes Patzelt et al.
FRONTIERS IN PHYSIOLOGY (2015)
The complement system in systemic lupus erythematosus: an update
Jonatan Leffler et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
Johanna T. Gustafsson et al.
AUTOIMMUNITY (2014)
Complement factor C5a induces atherosclerotic plaque disruptions
Anouk Wezel et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System onle Platelets in Systemic Lupus Erythematosus
Christian Lood et al.
PLOS ONE (2014)
Relation of Platelet C4d with All-Cause Mortality and Ischemic Stroke in Patients with Systemic Lupus Erythematosus
Amy H. Kao et al.
TRANSLATIONAL STROKE RESEARCH (2014)
Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways
Katie S. Wraith et al.
BLOOD (2013)
Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study
C. Bengtsson et al.
LUPUS (2012)
Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus - a possible link to venous thrombosis?
C. Lood et al.
LUPUS (2012)
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study
Johanna T. Gustafsson et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Effects of physiologically relevant dynamic shear stress on platelet complement activation
Saravan Kumar Shanmugavelayudam et al.
PLATELETS (2011)
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease
Christian Lood et al.
BLOOD (2010)
Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population
G. Sturfelt et al.
CLINICAL GENETICS (2010)
Complement Component C3 Binds to Activated Normal Platelets without Preceding Proteolytic Activation and Promotes Binding to Complement Receptor 1
Osama A. Hamad et al.
JOURNAL OF IMMUNOLOGY (2010)
C1q Inhibits Immune Complex-Induced Interferon-α Production in Plasmacytoid Dendritic Cells A Novel Link Between C1q Deficiency and Systemic Lupus Erythematosus Pathogenesis
Christian Lood et al.
ARTHRITIS AND RHEUMATISM (2009)
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells
B. Gullstrand et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies
E. I. B. Peerschke et al.
LUPUS (2009)
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study
Johanna Gustafsson et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets
O. A. Hamad et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Platelet C4d Is Associated With Acute Ischemic Stroke and Stroke Severity
Nidhi Mehta et al.
STROKE (2008)
Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency
G. Jonsson et al.
RHEUMATOLOGY (2007)
Platelet C4d is highly specific for systemic lupus erythematosus
JS Navratil et al.
ARTHRITIS AND RHEUMATISM (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Circulating platelet-derived microparticles in systemic lupus erythematosus - Association with increased thrombin generation and procoagulant state
J Pereira et al.
THROMBOSIS AND HAEMOSTASIS (2006)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) -: XXV.: Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients
J Calvo-Alén et al.
ARTHRITIS AND RHEUMATISM (2005)
Platelet activation leads to activation and propagation of the complement system
I del Conde et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Share Paper
